---
title: "风险评估 - Reviews, Revenue and Downloads in China | Apple App Store"
description: "对于正在 服用阿司匹林进行二级预防的患者，程序将引领您评估 风险并给予相关对策建议；对于准备服用阿司匹林进行 一级预防的患者，程序将评估您是否适合服用阿司匹林 和相关风险，并给予相关预防策略。目前阿司匹林使用 的常规剂量为75-100mg每天，部分研究显示阿司匹林 50mg每天同样可有效预防心脑血管事件发生"
---

# 风险评估 — China

![风险评估 App Icon](https://is1-ssl.mzstatic.com/image/thumb/Purple123/v4/56/1a/64/561a64d9-2cfd-6cd4-48f1-087fb4397c9a/AppIcon-0-1x_U007emarketing-0-0-85-220-10.png/400x400bb.png)

**Developer:** [Ashermed healthcare Communications](https://apptail.io/developer/ashermed-healthcare-communications-hlA)
**Category:** Health Fitness
**Rating:** 5.0/5 (1 ratings)
**Price:** Free
**Bundle ID:** com.ashermedAspirin
**Store:** Apple App Store
**Country:** China
**Version:** 1.0.4 (released 2019-09-20)
**Original Release:** 2019-03-24

**App Store Link:** [Download on Apple App Store](https://apps.apple.com/cn/app/app/id1446536811)
**AppTail Page:** [https://apptail.io/app/app-hWRe/china](https://apptail.io/app/app-hWRe/china)

## 风险评估 Description
对于正在 服用阿司匹林进行二级预防的患者，程序将引领您评估 风险并给予相关对策建议；对于准备服用阿司匹林进行 一级预防的患者，程序将评估您是否适合服用阿司匹林 和相关风险，并给予相关预防策略。目前阿司匹林使用 的常规剂量为75-100mg每天，部分研究显示阿司匹林 50mg每天同样可有效预防心脑血管事件发生

## 风险评估 Screenshots
- [Screenshot 1](https://is1-ssl.mzstatic.com/image/thumb/Purple123/v4/aa/5a/7c/aa5a7c48-dff5-e07c-4283-c4cd029885e5/pr_source.png/1242x2688.png)

## 风险评估 Rating Breakdown in China
- 5 stars: 1 (100%)
- 4 stars: 0 (0%)
- 3 stars: 0 (0%)
- 2 stars: 0 (0%)
- 1 stars: 0 (0%)




## 风险评估 Discovered Keywords
- 风险评估

## Apps Similar to 风险评估
- [移动随访](https://apptail.io/app/app-NhBb/china)
- [医知源-医生的最佳诊疗决策辅助工具](https://apptail.io/app/app-BHBc/china)
- [精准防艾1端](https://apptail.io/app/1-EJsd/china)
- [粒健康-身边的健康管理师](https://apptail.io/app/app-VRsd/china)
- [SkipTogether](https://apptail.io/app/skiptogether-uDLd/china)
- [智能镇痛助手](https://apptail.io/app/app-Wlgg/china)
- [嘉医有品医生版](https://apptail.io/app/app-xaXg/china)
- [术康Pro](https://apptail.io/app/pro-bgXg/china)
- [蝶生健康-甲状腺在线问诊平台](https://apptail.io/app/app-HxXg/china)
- [BioRhythm-Breast](https://apptail.io/app/biorhythm-breast-vnYg/china)

## 风险评估 Available In
- [China](https://apptail.io/app/app-hWRe/china)
- [Canada](https://apptail.io/app/app-hWRe/canada)
- [Chile](https://apptail.io/app/app-hWRe/chile)
- [Dominican Republic](https://apptail.io/app/app-hWRe/dominican-republic)
- [Algeria](https://apptail.io/app/app-hWRe/algeria)
- [Japan](https://apptail.io/app/app-hWRe/japan)
- [Mexico](https://apptail.io/app/app-hWRe/mexico)
- [Romania](https://apptail.io/app/app-hWRe/romania)
- [Sweden](https://apptail.io/app/app-hWRe/sweden)
- [United Arab Emirates](https://apptail.io/app/app-hWRe/united-arab-emirates)
- [United States](https://apptail.io/app/app-hWRe/united-states)

---

## About AppTail

[AppTail](https://apptail.io) is a mobile app intelligence platform providing app analytics, ASO (App Store Optimization) tools, keyword tracking, competitor analysis, revenue estimates, and review monitoring for iOS App Store apps. Track your app's performance, discover ranking keywords, monitor competitors, and analyze market trends.

- [Search Apps](https://apptail.io)
- [Top Charts](https://apptail.io/top-iphone-apps)
- [Sign Up for Full Access](https://app.apptail.io/signup?utm_campaign=ai-crawl&utm_content=footer)

*Data provided by [AppTail](https://apptail.io) - Mobile App Intelligence Platform*